Stay updated on T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.

Latest updates to the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check44 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the usual content, hiding the trial details, sponsor information, and contacts.SummaryDifference16%

- Check66 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s version. This change does not modify any study details or visible content.SummaryDifference0.0%

- Check73 days agoChange DetectedA line reading '2023 ( U.S. NIH Grant/Contract )' was added to the study details, updating the funding attribution for the DESTINY-Breast09 trial.SummaryDifference0.0%

Stay in the know with updates to T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.